New wound care dressing reduces use of antibiotics:
This article was originally published in Clinica
Patients receiving temporary heart pumps at the Cleveland Clinic Heart Center, are being treated with Arglaes, a new wound care dressing which can reduce the incidence of infection without the use of antibiotics. The dressing releases a constant stream of silver ions to the wound site for up to seven days, forming an antimicrobial barrier. Unlike antibiotics, it does not have induced resistance to any known bacteria. Arglaes was developed by Danish company Maersk Medical and is distributed in the US by Mundelein, Illinois-based Medline Industries. The product comes in the form of a transparent film with or without an absorbent calcium alginate pad.